Zydus Lifesciences gets USFDA OAI status for Jarod facility
Ahmedabad: Zydus Lifesciences has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has determined that the inspection classification of its injectables manufacturing facility located at Jarod, near Vadodara, Gujarat, India as “Official Action Indicated” (OAI).
"We wish to inform that the Company has received a report from the United States Food and Drug Administration (“USFDA”) for the inspection conducted at its injectables manufacturing facility located at Jarod, near Vadodara, Gujarat, India between April 15 and April 23, 2024," Zydus informed.
Headquartered in Ahmedabad, Zydus Lifesciences Limited is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer-related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Read also:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd